STATE STREET CORP - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 73 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$2,963,078
-18.2%
937,683
+0.2%
0.00%
Q2 2023$3,622,935
+83.1%
936,159
+31.0%
0.00%
Q1 2023$1,979,176
-21.7%
714,504
-49.1%
0.00%
Q4 2022$2,527,934
+82.8%
1,404,408
+115.3%
0.00%
Q3 2022$1,383,000
-11.4%
652,325
+12.4%
0.00%
Q2 2022$1,561,000
+93.4%
580,183
+212.0%
0.00%
Q1 2022$807,000
-12.1%
185,955
+4.9%
0.00%
Q4 2021$918,000
-5.2%
177,200
+12.4%
0.00%
Q3 2021$968,000157,7000.00%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders